Company Active LTD

Company profile

Cardiocrown Limited

CardioCrown

Cardiocrown Limited is a UK company with status active founded in 2019 based in Yorkshire and the Humber.

CRN
11988556
Founded
2019
Age
7

Overview

Legal name
RENEURAL TECHNOLOGIES LIMITED
Region
Yorkshire and the Humber
Registered address
14 KING STREET
INTERNATIONAL HOUSE
LEEDS
ENGLAND
LS1 2HL
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

10 events
28 Feb
2027

Accounts due

Accounts Due

Next accounts due date

18 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

04 Nov
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 May
2025

Accounts filed

Accounts

Last accounts made up date

04 Nov
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ0MTg3NTA0MGFkaXF6a2N4

Published 04 Nov 2024 11:05

15 Oct
2024

Certificate Change Of Name Company

Change-of-name

CERTNM | Transaction MzQzOTU0OTk1NGFkaXF6a2N4

Published 15 Oct 2024 11:22

28 Sep
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURDMllRUUlhZGlxemtjeA | Paper/PDF filed

Published 01 Oct 2024 06:31

28 Sep
2024

Memorandum Articles

Incorporation

MA | Transaction MzQzNjY4NTQzNmFkaXF6a2N4 | Paper/PDF filed

Published 29 Sep 2024 05:56

20 Sep
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzNjY4MzYzNmFkaXF6a2N4

Published 20 Sep 2024 12:05

10 May
2019

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2022
Funded years
2022, 2024
Age at first award
3 years

Projects

2024 Investment Accelerator Lead participant

NeuroMindXR:Mental Health Support for stroke survivors

1 Nov 2024 to 31 Jan 2026

Awarded
£192,447
Total cost £274,924

Annually, stroke affects approximately 15 million individuals worldwide, with the UK alone witnessing up to 119,100 new cases each year(Chohan SA et al., 2019). The ageing population contributes significantly to this burden, with projections indicating a 59% increase in the incidence of first-time strokes between 2015 and 2035 (Stroke Association, 2020). ...

2022 Grant for R&D Lead participant

NeuroVive

1 Nov 2022 to 30 Apr 2023

Awarded
£49,987
Total cost £49,987

A stroke is a serious life-threatening medical condition that happens when the blood supply to part of the brain is cut off. Stroke causes severe physical disability such as attention deficiency, pain, weakness, and paralysis. Such impairments can result in a loss of ability to carry out typical day-to-day activities. This means that people are made depen...

Product types

Grant for R&D Investment Accelerator